See more : Deutsche EuroShop AG (DEQ.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Medicus Pharma Ltd. Common Stock (MDCX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicus Pharma Ltd. Common Stock, a leading company in the None industry within the None sector.
You may be interested
- GASE Energy, Inc. (GASE) Income Statement Analysis – Financial Results
- Karnov Group AB (publ) (0A39.L) Income Statement Analysis – Financial Results
- Duell Oyj (DUELL.HE) Income Statement Analysis – Financial Results
- Alpcot Holding AB (publ) (ALPCOT-B.ST) Income Statement Analysis – Financial Results
- Altimmune, Inc. (ALT) Income Statement Analysis – Financial Results
Medicus Pharma Ltd. Common Stock (MDCX)
Unable to fetch income statement for: MDCX
Medicus Pharma Ltd. Announces First Patient Randomized in Phase 2 Trial of SKNJCT-003 for the Treatment of Nodular Basal Cell Carcinoma in Adults
The clinical study will randomize up to 60 patients across 6 trial sites in the United States Toronto, Ontario--(Newsfile Corp. - August 27, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) ("Medicus" or the "Company") announces the enrollment of...
Medicus Pharma Ltd. Submits Updated Phase 2 Clinical Protocol to Non-Invasively Treat Basal Cell Carcinoma of the Skin
THE FULL PACKAGE INCLUDES AN UPDATED INVESTIGATOR BROCHURE, CMC (CHEMISTRY, MANUFACTURING AND CONTROLS), STABILITY AND STERILTY DATA Toronto, Ontario--(Newsfile Corp. - July 15, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) ("Medicus" or the "Company") is pleased to announce...
Medicus Pharma Ltd. Announces Closing of Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes
Toronto, Ontario--(Newsfile Corp. - July 5, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) (the "Company") is pleased to announce that it has completed its previously announced non-brokered private placement (the "Equity Offering") of 2,922,500 common shares of the...
Medicus Pharma Ltd. Announces Proposed Non-Brokered Private Placement of Common Shares and Conversion of Convertible Notes
Toronto, Ontario--(Newsfile Corp. - June 26, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) (the "Company") is pleased to announce that it intends to complete a non-brokered private placement (the "Equity Offering") of 2,922,500 common shares of the Company...
Medicus Pharma Ltd. Announces Filing of Registration Statement for Proposed Initial Public Offering in the United States
Toronto, Ontario--(Newsfile Corp. - May 29, 2024) - Medicus Pharma Ltd. (TSXV: MDCX) (FSE: N46) (the "Company") is pleased to announce that it has publicly filed a registration statement on Form F-1 (the "Registration Statement") with the U.S. Securities and...
Source: https://incomestatements.info
Category: Stock Reports